MarketPeel
Insider Trading Intelligence
Pricing
…
ND

Nathan J. Dowden

TRDA
CHIEF OPERATING OFFICER · ENTRADA THERAPEUTICS, INC. · CIK 0001873392
FILING MIX · LIFETIME31%/69%
BUYS
20
SELLS
45
TOTAL VALUE
$2.23M
COMPANIES
1
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
198,588
AVG SELL PX
$14.87
TRADE KIND
SHOWING 65 / 65
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
29 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Nathan J. Dowden, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d29+41.38%+0.77%+0.17%+0.60%+1.68%—
14d29+55.17%-2.52%-0.40%-2.12%-0.41%—
30d29+48.28%-0.60%+1.80%-0.44%+6.20%—
60d29+44.83%-2.99%+3.08%-6.07%+1.13%—
90d29(1 pending)+42.86%-3.44%+4.48%-7.92%-3.37%—
180d29(3 pending)+76.92%-15.30%+7.83%-23.13%-28.97%—
1y29(3 pending)+80.77%-21.05%+16.71%-37.76%-33.46%—
2y29(8 pending)+66.67%-15.66%+51.24%-66.91%-68.64%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TRDA · 198,588 shares · as of May 4, 2026
058,715117,430176,144234,85920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 45 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
15,000——49,831May 4, 2026May 4, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
President & COO
15,000$1.74$26.1K213,588May 4, 2026May 4, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,000$15.33$230.0K198,588May 4, 2026May 4, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,894$13.05$155.2K198,588Mar 10, 2026Mar 11, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,116$13.02$40.6K210,482Mar 9, 2026Mar 11, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
14,038$11.76$165.0K213,598Mar 3, 2026Mar 3, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
7,223$11.66$84.2K227,636Mar 2, 2026Mar 3, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
83,200——83,200Mar 1, 2026Mar 3, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
55,800——234,859Mar 1, 2026Mar 3, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
1,746$5.43$9.5K179,059Sep 2, 2025Sep 4, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
5,144$11.68$60.1K180,805Mar 3, 2025Mar 4, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,800——185,949Mar 1, 2025Mar 4, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,800——90,800Mar 1, 2025Mar 4, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
847$16.00$13.6K125,149Sep 26, 2024Sep 30, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,904$15.07$28.7K125,996Sep 9, 2024Sep 10, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
399$15.19$6.1K127,900Sep 6, 2024Sep 10, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
171$15.13$2.6K128,299Sep 5, 2024Sep 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
983$15.42$15.2K128,470Sep 4, 2024Sep 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
483$15.76$7.6K129,624Sep 3, 2024Sep 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
15$17.70$266129,453Sep 3, 2024Sep 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
156$16.93$2.6K129,468Sep 3, 2024Sep 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
26,595$16.26$432.4K130,609Aug 16, 2024Aug 20, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
20,000——64,831Aug 16, 2024Aug 20, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
502$16.70$8.4K130,107Aug 16, 2024Aug 20, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
President & COO
20,000$1.74$34.8K157,204Aug 16, 2024Aug 20, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,826$12.32$22.5K137,204Mar 6, 2024Mar 8, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
1,486$12.28$18.2K139,030Mar 5, 2024Mar 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
343$12.42$4.3K140,925Mar 4, 2024Mar 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
President & COO
409$13.37$5.5K140,516Mar 4, 2024Mar 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,100——50,100Mar 1, 2024Mar 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,100——81,268Mar 1, 2024Mar 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,000——141,268Mar 1, 2024Mar 5, 2024 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
913$13.43$12.3K48,227Sep 6, 2023Sep 6, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
59$14.01$82648,168Sep 6, 2023Sep 6, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
436$14.46$6.3K49,140Sep 5, 2023Sep 6, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,200——49,576Sep 1, 2023Sep 6, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,500——21,500Sep 1, 2023Sep 6, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,097$16.02$113.7K42,473Jun 22, 2023Jun 22, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,885$14.94$132.7K49,570Jun 20, 2023Jun 22, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,028$11.60$11.9K72,655Mar 2, 2023Mar 3, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,000——43,000Mar 1, 2023Mar 3, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,400——73,683Mar 1, 2023Mar 3, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,500——21,500Mar 1, 2023Apr 19, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,200——58,455Mar 1, 2023Apr 19, 2023 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,100$24.05$50.5K45,283Oct 31, 2022Nov 2, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,034$20.10$61.0K53,697Oct 25, 2022Oct 27, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
5,414$20.97$113.5K48,283Oct 25, 2022Oct 27, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
900$21.85$19.7K47,383Oct 25, 2022Oct 27, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,302$19.66$25.6K56,731Oct 24, 2022Oct 24, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,102$18.88$20.8K58,033Oct 24, 2022Oct 24, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,771$18.29$50.7K59,135Oct 21, 2022Oct 24, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
905$18.07$16.4K61,906Oct 20, 2022Oct 24, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
215$16.25$3.5K62,811Sep 26, 2022Sep 28, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,329$15.32$20.4K63,026Sep 26, 2022Sep 28, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
1,018$15.07$15.3K64,355Sep 23, 2022Sep 23, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
3,275$15.13$49.5K65,373Sep 21, 2022Sep 23, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
100$15.01$1.5K68,648Sep 15, 2022Sep 19, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
865$15.06$13.0K68,748Sep 9, 2022Sep 12, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
912$15.15$13.8K69,613Sep 8, 2022Sep 12, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,632——70,525Sep 1, 2022Sep 6, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,788——33,788Jul 1, 2022Jul 6, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
Chief Operating Officer
7,714$13.00$100.3K64,893Jun 27, 2022Jun 29, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,263——72,607Mar 1, 2022Mar 3, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
67,575——67,575Mar 1, 2022Mar 3, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,148——95,148Oct 28, 2021Nov 1, 2021 ↗View →
Other insiders · TRDA
Loading peer insiders…
About this filer
CIK 0001873392
ROLE
Chief Operating Officer
PRIMARY
TRDA
COMPANIES
1
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001873392DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback